Changtao Jiang

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

Lulu Sun, Cen Xie, Guang Wang et al. · Nature Medicine · 2018 · 1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +13

Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome

Xinyu Qi, Chuyu Yun, Lulu Sun et al. · Nature Medicine · 2019 · 846 citations · Full text

Medicine, Endocrinology, Immunology +12

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Fei Li, Changtao Jiang, Kristopher W. Krausz et al. · Nature Communications · 2013 · 690 citations · Full text

Life Sciences, Cell Biology, Pharmacology +14

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Changtao Jiang, Cen Xie, Fei Li et al. · Journal of Clinical Investigation · 2014 · 675 citations · Full text

Life Sciences, Nutrition, Pharmacology +15

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

Changtao Jiang, Cen Xie, Ying Lv et al. · Nature Communications · 2015 · 537 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16